Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Galectin

Galectins are a class of proteins that bind specifically to β-galactoside sugars, such as N-acetyllactosamine (Galβ1-3GlcNAc or Galβ1-4GlcNAc), which can be bound to proteins by either N-linked or O-linked glycosylation. They are also termed S-type lectins due to their dependency on disulphide bonds for stability and carbohydrate binding. There have been about 15 galectins discovered in mammals, encoded by the LGALS genes, which are numbered in a consecutive manner. Only galectin-1, -2, -3, -4, -7, -7B, -8, -9, -9B, 9C, -10, -12, -13, -14, and -16 have been identified in humans. Galectin-5 and -6 are found in rodents, whereas galectin-11 and -15 are uniquely found in sheep and goats. Members of the galectin family have also been discovered in other mammals, birds, amphibians, fish, nematodes, sponges, and some fungi. Unlike the majority of lectins they are not membrane bound, but soluble proteins with both intra- and extracellular functions. They have distinct but overlapping distributions[2] but found primarily in the cytosol, nucleus, extracellular matrix or in circulation. Although many galectins must be secreted, they do not have a typical signal peptide required for classical secretion. The mechanism and reason for this non-classical secretion pathway is unknown.

  • TD139
    T51211450824-22-2In house
    TD139 is a small molecule inhibitor of inhaled galectin-3 (Gal-3) with potential anti-fibrotic activity, commonly used in the study of idiopathic pulmonary fibrosis.
    • $64
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • GB1107
    T153721978336-61-6
    GB1107 is an effective and selective Galectin-3 inhibitor with a Kd of 37 nM.
    • $53
    In Stock
    Size
    QTY
  • OTX008
    T16413286936-40-1
    OTX008 (PTX008) is a selective galectin-1 inhibitor.
    • $64
    In Stock
    Size
    QTY
  • Thiodigalactoside
    T3807451555-87-4
    Thiodigalactoside (TDG), a non-metabolizable disaccharide, serves as an orally active, potent galectin (GAL) inhibitor, exhibiting Kd values of 24 μM and 49 μM for GAL1 and GAL3, respectively. Demonstrating anti-inflammatory and anti-cancer properties, it significantly diminishes body weight gain in diet-induced obese rats.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • G3-C12 acetate(848301-94-0 free base)
    T11346L
    G3-C12 acetate shows anticancer activity. is a galectin-3 binding peptide, with Kd of 88 nM.
    • $48
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • DB21, Galectin-1 Antagonist
    T826051623027-80-4
    DB21, Galectin-1 Antagonist, is a peptidomimetic conjugated with dibenzofuran, serving as an allosteric inhibitor of galectin-1 (GAL1) interactions with glycans on cell surfaces. This compound enhances the inhibition of angiogenesis and tumor growth in melanoma, lung adenocarcinoma, and ovarian cancer models [1].
    • Inquiry Price
    Size
    QTY
  • Galectin-3/galectin-8-IN-1
    T79380
    Galectin-3 galectin-8-IN-1 (Compound 53) serves as a dual inhibitor of the Galectin-3 and galectin-8 C-terminal domains, exhibiting dissociation constants (Kd) of 4.12 μM for Galectin-3 and 6.04 μM for galectin-8. It effectively impedes the migration of MRC-5 lung fibroblast cells and is utilized in cancer and tissue fibrosis research [1].
    • Inquiry Price
    Size
    QTY
  • Galectin-3/galectin-8-IN-2
    T79381
    Galectin-3 galectin-8-IN-2 (Compound 57) is a dual inhibitor targeting the C-terminal domains of Galectin-3 and galectin-8, with dissociation constants (Kd) of 12.8 μM and 2.06 μM, respectively. It effectively inhibits MRC-5 lung fibroblast cell migration and serves as a potential research tool for studying cancer and tissue fibrosis [1].
    • Inquiry Price
    Size
    QTY
  • Galectin-3 antagonist 2
    T745382921603-02-1
    Galectin-3, a β-galactoside-specific carbohydrate recognition protein (lectin), facilitates the migration of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells and demonstrates resistance to pharmaceutical interventions.
    • $1,520
    Backorder
    Size
    QTY